vTv Therapeutics, Inc. Class A Forecast, price target & analysts
$16.50
5.64%
today
Nasdaq,
Apr 04, 08:56 pm CET
vTv Therapeutics, Inc. Class A Target price 2025 - Analyst rating & recommendation
Powered by
vTv Therapeutics, Inc. Class A Classifications & Recommendation:
Buy
100%
vTv Therapeutics, Inc. Class A Price Target
| Target Price | $35.00 |
| Price | $17.49 |
| Potential |
100.11%
register free of charge
|
| Number of Estimates | 1 |
|
1 Analyst has issued a vTv Therapeutics, Inc. Class A price target 2026.
The average vTv Therapeutics, Inc. Class A target price is $35.00.
This is
100.11%
register free of charge
|
|
| A rating was issued by 1 analysts: 1 Analysts recommend vTv Therapeutics, Inc. Class A to buy, 0 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the vTv Therapeutics, Inc. Class A stock has an average upside potential 2026 of
100.11%
register free of charge
|
Current vTv Therapeutics, Inc. Class A Upgrades & Downgrades
Create a Premium account to unlock Upgrades/Downgrades.
Learn more
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Alliance Global Partners |
Locked
➜
Locked
|
Locked | Dec 09 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
Alliance Global Partners:
Locked
➜
Locked
|
Dec 09 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
